FSD Pharma OverviewFSD Pharma EBIT
EBIT (Earnings Before Interest and Taxes) analysis for HUGE.
Quarterly EBIT
-$3.34M
↑ 62.13% YoY
As of Jun 30, 2024
Annual EBIT (TTM)
-$10.96M
↑ 66.38% YoY
Trailing 12 months ending Jun 30, 2024
FSD Pharma OverviewEBIT (Earnings Before Interest and Taxes) analysis for HUGE.
As of Jun 30, 2024
Trailing 12 months ending Jun 30, 2024